Rest Therapeutics
- Address
- 105 Place Eugene Bataillon
Sponsor Overview
Specializations
Post-Traumatic Stress Disorder and trauma-related conditions
Rest Therapeutics is active in clinical research focused on Post-Traumatic Stress Disorder (PTSD), with interest in disorders linked to persistent stress responses, fear processing, and disrupted emotional regulation.
- PTSD symptom management
- Trauma-related psychiatric disorders
- Stress-response modulation
The sponsor’s research activity is centered on central nervous system conditions with a therapeutic emphasis on brain-based disorders affecting cognition, mood, and resilience to traumatic stress.
Brain disease therapeutics
Its clinical development interests extend to brain diseases, reflecting a focus on treatments for neurological and neuropsychiatric conditions where restoration of normal brain function is a key objective.
- Neuropsychiatric disorders
- Central nervous system therapeutics
- Novel molecular treatments
The available trial activity indicates attention to therapeutics intended for disorders of the nervous system, with particular relevance to conditions involving altered stress circuitry and mental health outcomes.
Psychiatric and mental health research
Rest Therapeutics shows interest in psychiatric research areas that overlap with trauma, anxiety, and emotional dysregulation, especially where new medicines may address unmet needs in mental health care.
- Anxiety-related symptoms
- Emotional regulation disorders
- Stress and fear circuitry
This therapeutic domain connects its work to conditions in which brain-targeted interventions may influence behavioral and psychological outcomes.
Early clinical development in neurologic indications
The sponsor’s active trial portfolio includes investigation of a new molecule for brain-related diseases, indicating involvement in early-stage clinical research for novel pharmaceutical approaches within neurology and psychiatry.
- Novel molecule development
- Translational neuroscience
- Human brain safety and tolerability research
Its research landscape is concentrated in France, with clinical activity based in Montpellier and a single active study site.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase I Study of Single and Escalating Doses of a Novel Molecule in Healthy Volunteers for the Treatment of Post-Traumatic Stress Disorder (PTSD) |  Belgium | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Mental Disorders1 trial150 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centre- Address
- Avenue Hippocrate 15, 4000 Liège
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Rest Therapeutics.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.